News

Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without ...
The REV102 program originated from a joint venture between Rallybio and Recursion focused on the discovery and development of novel, orally available small molecule inhibitors of ENPP1 for the ...